Intermittent Fasting and Immune Aging: A Scientific Review

Introduction

Aging is characterized by a decline in immune function, known as immunosenescence, and a state of chronic low-grade inflammation, termed inflammaging. Both contribute to increased susceptibility to infections, reduced vaccine efficacy, and the development of age-related diseases. This review investigates the current scientific understanding of how intermittent fasting (IF), a dietary pattern involving alternating periods of eating and fasting, may impact these aspects of immune aging.

The Study in Detail

The review, titled "Intermittent fasting and immune aging: implications for immunosenescence, inflammaging, neuroinflammation, and frailty," was published in Frontiers in Nutrition (2026 Jan 21;13:1736969) by Alkawamleh D, Madkour MI, Kalam F, Abdelrahim DN, Abdallah HW, and Faris ME. The authors are affiliated with institutions including King Hussein Cancer Center, Applied Science Private University, University of Sharjah, and The Ohio State University.

This comprehensive review synthesizes preclinical and human study findings to explore the mechanisms by which IF might exert immunoregulatory effects. The authors focused on how IF influences metabolic remodeling, cellular stress responses, and inflammatory signaling pathways. Key findings from the reviewed literature suggest that IF:

• Attenuates the production of pro-inflammatory cytokines.
• Enhances autophagy, a cellular process for clearing damaged components.
• Improves immune cell function.
• Potentially delays immunosenescence and reduces inflammaging in middle-aged and older populations.

Furthermore, the review indicates that IF may offer protection against neuroinflammation and cognitive decline by:

• Reducing oxidative stress.
• Activating AMPK-SIRT1 and ketone signaling via β-hydroxybutyrate (BHB).
• Enhancing neuroplasticity.
• Upregulating brain-derived neurotrophic factor.
• Suppressing pro-inflammatory cytokines and inflammation in the aging brain.

The authors also discuss how IF, by reducing oxidative stress and inflammaging, could potentially mitigate frailty in older adults or delay its progression if initiated earlier. However, the review emphasizes that most evidence stems from short- to medium-term studies conducted in relatively healthy populations, with benefits often comparable to continuous calorie restriction. There is limited data on long-term safety, potential adverse effects, and outcomes in frail older adults.

Assessment

This review provides a valuable overview of the current understanding of intermittent fasting's potential role in immune aging. Its strength lies in integrating insights from immunometabolism and gerontology, offering a holistic perspective on complex biological processes. By highlighting specific molecular pathways and cellular mechanisms, the review helps to elucidate how IF might exert its beneficial effects on the immune system and brain function during aging.

However, the authors appropriately point out significant limitations in the existing research. The reliance on short- to medium-term studies and relatively healthy cohorts means that the generalizability of these findings, particularly to frail or chronically ill older adults, is not yet established. The lack of long-term safety data and direct comparisons with isocaloric non-fasting regimens also represents a critical gap. The review's call for more randomized controlled trials, especially in vulnerable populations, and long-term follow-up studies, underscores the need for more robust evidence before broad recommendations can be made.

Practical Relevance

For individuals interested in strategies to promote healthy aging, this review suggests that intermittent fasting holds promise as a non-pharmacological approach to support immune function and potentially mitigate age-related decline. The mechanisms discussed, such as reduced inflammation and enhanced cellular repair processes, are fundamental to maintaining overall health. While the evidence is still developing, adopting dietary patterns that incorporate periods of fasting, under appropriate guidance, might contribute to improved metabolic health and immune resilience.

It is crucial to understand that the benefits observed in studies often parallel those of general calorie restriction, indicating that overall dietary quality and energy balance remain paramount. Individuals, especially older adults or those with pre-existing health conditions, should consult with healthcare professionals before making significant dietary changes, including implementing intermittent fasting protocols. The potential benefits must be weighed against individual health status, nutritional needs, and the importance of ensuring adequate nutrient intake during eating windows.

Conclusion

The scientific literature reviewed suggests that intermittent fasting may positively influence immune aging by modulating inflammation, enhancing cellular repair, and improving immune cell function. While promising, current evidence is primarily from short-term studies in healthy populations, necessitating further long-term research, particularly in frail older adults. Future studies need to establish long-term safety, efficacy, and optimal application before IF can be routinely recommended as a strategy for healthy immune aging.